A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

Data to be presented will highlight the progress of SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for delaying the ...

CAR-T was developed to wipe out hard-to-treat blood cancers. But the cells that go bad in leukemias and lymphomas — immune ...

Monday: Colder; breezy in the morning, with a high of 32 and low of 20 degrees.

The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to ...

Gut-microbe–derived trimethylamine (TMA) blocks a key immune protein, reducing inflammation and improving blood-sugar control.

A new study has developed a powerful computational method that can detect how genes interact with each other to influence ...

Adding to the growing body of research that proves our microbiome is a powerful ally in fighting disease, scientists have ...

Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.

An international research team led by Professor Marc-Emmanuel Dumas at Imperial College London & CNRS together with Prof.

Kidney diseases, including chronic kidney disease (CKD) and acute kidney injury (AKI), represent a major global public health burden. These diseases cause ...